RightFit
Not yet recruitingNot applicable

Insul-In This Together: Leveraging Family Support and Diabetes Technology for Adolescents Living With Type 1 Diabetes

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
12 Years and older
Sex
Female only
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: Questionnaires

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "Adolescent and parent participants will: Attend 8 weekly 30-minute videoconference sessions with an interventionist Complete online surveys, share diabetes device data, and conduct at-home A1c tests 3-5 times over a 12-month period"
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests whether the “Insul-In This Together” family program improves blood sugar and quality of life for teens with type 1 diabetes. Teens and their parents or caregivers will attend 8 weekly video sessions and complete study tasks over 12 months. All families get the program, either right away or after 6 months.

The goal of this clinical trial is to learn if the "Insul-In This Together" family program works to improve outcomes for adolescents living with type 1 diabetes. It will also learn about how the program influences diabetes-related factors, including parenting. The main questions it aims to answer are: Does this program improve glycemic (blood glucose) outcomes? Does this program improve adolescent quality of life related to diabetes? Researchers will offer the program to all participating families, with one group receiving the program right after enrollment and another group receiving the program 6 months later. Adolescent and parent participants will: Attend 8 weekly 30-minute videoconference sessions with an interventionist Complete online surveys, share diabetes device data, and conduct at-home A1c tests 3-5 times over a 12-month period

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Teens must be 12–17 years old.
  • Teens must have had type 1 diabetes for at least 6 months.
  • Teens must live with the parent or caregiver taking part.
  • Parents or caregivers must live with a teen who qualifies and is taking part.
  • Both teens and parents or caregivers must live in the United States.
  • Both teens and parents or caregivers must be able to use English.

Who can't join

  • A serious or widespread physical or mental health condition that would limit taking part in the program or study tests, such as major delays in development.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * For adolescent participants: ages 12-17, diagnosed with type 1 diabetes for at least 6 months, US resident, English proficiency, and resides with the participating parent/caregiver. * For parent participants: residing with eligible and participating adolescent, US resident, and English proficiency. Exclusion Criteria: * Severe or pervasive physical or mental health condition that would limit participation in data collection or the intervention (e.g., pervasive developmental delays).

Study sites (1)

CA